Clinical Trials Browser

Has results × Triple Negative Breast Neoplasms × copanlisib × Clear all

NCT04345913 2026-03-19

Testing the Addition of Copanlisib to Eribulin in Metastatic Triple Negative Breast Cancer

Phase 1/2 Active not recruiting

24 enrolled 24 charts

Triple Negative Breast Neoplasms